Medicare Rx Benefit Could Help Ignite COX-2 Market – Pharmacia’s Hassan
Executive Summary
A Medicare drug benefit could help jump-start the stalled COX-2 inhibitor market, Pharmacia CEO Fred Hassan told analysts during the company's annual investor day in New York City Nov. 28
You may also be interested in...
Pharmacia Bextra Pre-Launch Will Develop “Real Life Experience” With Drug
Pharmacia will pre-launch Bextra with select physicians to gather "real life experience" in advance of the COX-2 inhibitor's full launch in April
Pharmacia Bextra Pre-Launch Will Develop “Real Life Experience” With Drug
Pharmacia will pre-launch Bextra with select physicians to gather "real life experience" in advance of the COX-2 inhibitor's full launch in April
Pharmacia Bextra Promotions Could Emphasize Rapid Onset Of Action
Pharmacia's promotion strategy for Bextra (valdecoxib) appears to be emphasizing the second generation COX-2 inhibitor's rapid onset of action